Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Miller

Showing results (221-230 of 290) with videos related to

Pageof 29
Sort By:
BJU International|March 24, 2018
Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostateAndreas Maxeiner, Beatrice Kittner, Conrad Blobel, et al.
Prostate Cancer and Prostatic Diseases|May 15, 2020
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancerNeal Shore, Celestia S Higano, Daniel J George, et al.
BMC Cancer|January 8, 2019
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access programAxel Heidenreich, Silke Gillessen, Daniel Heinrich, et al.
Clinical Genitourinary Cancer|July 18, 2019
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access ProgramFred Saad, Silke Gillessen, Daniel Heinrich, et al.
The Lancet. Digital Health|December 17, 2025
App-based therapy for female patients with urinary incontinence in Germany (DINKS): a single-blind, randomised, controlled trialAxel Haferkamp, Lisa Frey, Gregor Duwe, et al.
Urologia Internationalis|April 6, 2018
Perioperative Changes and Progress in Photoselective Vaporization of the Prostate with GreenLight XPS 180 W System: A Single Center ExperienceMaximilian Reimann, Nikita Fishman, Zenai Almedom, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2012
Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomyZofia Wotschofsky, Jonas Busch, Monika Jung, et al.
Surgical Endoscopy|April 4, 2013
Laparoendoscopic single-site (LESS) varicocelectomy with reusable components: comparison with the conventional laparoscopic techniqueFrank Friedersdorff, Seven Johannes Aghdassi, Peter Werthemann, et al.
European Urology|December 8, 2009
Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristicsBertrand Tombal, Kurt Miller, Laurent Boccon-Gibod, et al.
World Journal of Urology|August 22, 2015
The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsyHannes Cash, Andreas Maxeiner, Carsten Stephan, et al.
Pageof 29

Showing results (221-230 of 290) with videos related to

Sort By:
Pageof 29
BJU International|March 24, 2018
Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostateAndreas Maxeiner, Beatrice Kittner, Conrad Blobel, et al.
Prostate Cancer and Prostatic Diseases|May 15, 2020
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancerNeal Shore, Celestia S Higano, Daniel J George, et al.
BMC Cancer|January 8, 2019
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access programAxel Heidenreich, Silke Gillessen, Daniel Heinrich, et al.
Clinical Genitourinary Cancer|July 18, 2019
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access ProgramFred Saad, Silke Gillessen, Daniel Heinrich, et al.
The Lancet. Digital Health|December 17, 2025
App-based therapy for female patients with urinary incontinence in Germany (DINKS): a single-blind, randomised, controlled trialAxel Haferkamp, Lisa Frey, Gregor Duwe, et al.
Urologia Internationalis|April 6, 2018
Perioperative Changes and Progress in Photoselective Vaporization of the Prostate with GreenLight XPS 180 W System: A Single Center ExperienceMaximilian Reimann, Nikita Fishman, Zenai Almedom, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2012
Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomyZofia Wotschofsky, Jonas Busch, Monika Jung, et al.
Surgical Endoscopy|April 4, 2013
Laparoendoscopic single-site (LESS) varicocelectomy with reusable components: comparison with the conventional laparoscopic techniqueFrank Friedersdorff, Seven Johannes Aghdassi, Peter Werthemann, et al.
European Urology|December 8, 2009
Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristicsBertrand Tombal, Kurt Miller, Laurent Boccon-Gibod, et al.
World Journal of Urology|August 22, 2015
The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsyHannes Cash, Andreas Maxeiner, Carsten Stephan, et al.
Pageof 29